TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
TELA

Tela Bio Inc

Healthcare · Medical Devices

1.30$ +9.3% vs. previous close Closing price · As of: Sep 17, 2026

Ownership

Ownership Structure

Who owns Tela Bio Inc (TELA)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 47.9% of the shares are freely tradable; institutional investors hold 69.0%.

Institutional ownership ?Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings. 69.0%
Insiders ?Share of the stock held by the executives, founders and major shareholders of the company itself. 8.3%
Float ?Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders. 47.9%
Short % of float ?Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices. 1.2%
Shares Outstanding ?Total number of shares issued. Price times share count gives market cap. 45Mio.

Largest Shareholders

Institutions

Institutions TELA
Name Stake (%) Shares Change (%) Date
Essex Woodlands Health Ventures 17.18 7,714,709 +0.0 06/30/2026
Nantahala Capital Management, LLC 11.46 5,144,114 +0.6 03/31/2026
Stonepine Capital Management Llc 5.83 2,617,252 +11.3 03/31/2026
SILVERARC CAPITAL MANAGEMENT, LLC 5.03 2,259,312 -14.7 03/31/2026
Vanguard Capital Management, LLC 3.43 1,540,624 +0.0 03/31/2026
Dafna Capital Management LLC 3.21 1,441,029 +0.0 06/30/2026
Perkins Capital Management Inc 3.16 1,418,328 +1.5 03/31/2026
UBS Group AG 2.36 1,059,524 -29.4 03/31/2026
Citigroup Inc 1.67 750,000 +0.0 03/31/2026

Funds

Funds TELA
Name Stake (%) Shares Change (%) Date
Vanguard MStar Total Stk Mkt Idx Invest 2.56 1,149,678 +0.0 07/31/2026

Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.

Insider holdings

Insider holdings TELA
Person Role Shares Value As of Type
Getz Heather C Chief Executive Officer 532,500 692,250 $ Aug 17, 2026 direct
Capper Joseph H Director 104,827 136,275 $ Sep 15, 2026 direct
Plovanic William J. Director 44,530 57,889 $ Jul 15, 2026 direct

Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.

Insiders

Insider Transactions

Insider Transactions
Date Person Role Type Shares Price Value
Sep 15, 2026 Capper Joseph H Director Buy 50,000 1.06 52,940
Sep 14, 2026 Capper Joseph H Director Buy 25,000 1.02 25,503
Aug 17, 2026 Getz Heather C Chief Executive Officer Buy 12,500 0.6649 8,311
Aug 14, 2026 Getz Heather C Chief Executive Officer Buy 15,000 0.6978 10,467
Aug 3, 2026 Getz Heather C Chief Executive Officer Other 500,000 0.00
Jul 15, 2026 Plovanic William J. Director Other 20,930 0.785 16,430
Jul 15, 2026 Capper Joseph H Director Other 6,227 0.785 4,888

Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?